Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma
NCT00705250Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in Hodgkin lymphoma (HL), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 2008; status: completed.
02
Drugs
bendamustine
03
Conditions
Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00705250.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00705250.